PFIZER INC Gain (Loss) on Disposition of Assets
PFIZER INC (PFE) reported Gain (Loss) on Disposition of Assets of $0 for the 3-month period ending 2023-10-01, per its 10-Q filed 2023-11-08.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2023-11-08
- PFIZER INC gain (loss) on disposition of assets for the quarter ending 2023-10-01 was $0.00.
- PFIZER INC gain (loss) on disposition of assets for the quarter ending 2023-07-02 was -$5.00M.
- PFIZER INC gain (loss) on disposition of assets for the quarter ending 2023-04-02 was $7.00M, a 600.00% increase year-over-year.
- PFIZER INC gain (loss) on disposition of assets for the quarter ending 2022-12-31 was $6.00M.
- PFIZER INC gain (loss) on disposition of assets for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- PFIZER INC gain (loss) on disposition of assets for fiscal 2021 was $99.00M.
- PFIZER INC gain (loss) on disposition of assets for fiscal 2020 was -$237.00M, a 840.63% decline from fiscal 2019.
- PFIZER INC gain (loss) on disposition of assets for fiscal 2019 was $32.00M, a 54.93% decline from fiscal 2018.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2023-10-01 | $0.00 10-Q · filed 2023-11-08 | -$5.00M derived: sum of 2 quarters · filed 2023-11-08 | $2.00M 10-Q · filed 2023-11-08 | $8.00M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2023-07-02 | -$5.00M 10-Q · filed 2023-08-09 | $2.00M 10-Q · filed 2023-08-09 | $8.00M derived: sum of 3 quarters · filed 2023-08-09 | $1.00M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2023-04-02 | $7.00M 10-Q · filed 2023-05-10 | $13.00M derived: sum of 2 quarters · filed 2023-05-10 | $6.00M derived: sum of 3 quarters · filed 2023-11-08 | $6.00M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$1.00M derived: sum of 2 quarters · filed 2023-11-08 | -$1.00M derived: sum of 3 quarters · filed 2023-11-08 | $0.00 10-K · filed 2023-02-23 | |
| 2022-10-02 | -$7.00M 10-Q · filed 2023-11-08 | -$7.00M derived: sum of 2 quarters · filed 2023-11-08 | -$6.00M 10-Q · filed 2023-11-08 | -$6.00M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-07-03 | $0.00 10-Q · filed 2023-08-09 | $1.00M 10-Q · filed 2023-08-09 | $1.00M derived: sum of 3 quarters · filed 2023-08-09 | $2.00M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-04-03 | $1.00M 10-Q · filed 2023-05-10 | $1.00M derived: sum of 2 quarters · filed 2023-05-10 | $2.00M derived: sum of 3 quarters · filed 2023-05-10 | $60.00M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.00M derived: sum of 2 quarters · filed 2023-02-23 | $59.00M derived: sum of 3 quarters · filed 2023-02-23 | $99.00M 10-K · filed 2023-02-23 | |
| 2021-10-03 | $1.00M 10-Q · filed 2022-11-09 | $59.00M derived: sum of 2 quarters · filed 2022-11-09 | $99.00M 10-Q · filed 2022-11-09 | -$139.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-07-04 | $58.00M 10-Q · filed 2022-08-10 | $98.00M 10-Q · filed 2022-08-10 | -$140.00M derived: sum of 3 quarters · filed 2023-02-23 | -$138.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-04-04 | $39.00M 10-Q · filed 2022-05-11 | -$198.00M derived: sum of 2 quarters · filed 2023-02-23 | -$196.00M derived: sum of 3 quarters · filed 2023-02-23 | -$197.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | -$237.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$235.00M derived: sum of 2 quarters · filed 2023-02-23 | -$236.00M derived: sum of 3 quarters · filed 2023-02-23 | -$237.00M 10-K · filed 2023-02-23 | |
| 2020-09-27 | $2.00M 10-Q · filed 2021-11-12 | $1.00M derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | -$1.00M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-28 | -$1.00M 10-Q · filed 2021-08-12 | -$2.00M 10-Q · filed 2021-08-12 | -$3.00M derived: sum of 3 quarters · filed 2022-02-24 | $29.00M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-29 | -$1.00M 10-Q · filed 2021-05-13 | -$2.00M derived: sum of 2 quarters · filed 2022-02-24 | $30.00M derived: sum of 3 quarters · filed 2022-02-24 | $30.00M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $31.00M derived: sum of 2 quarters · filed 2022-02-24 | $31.00M derived: sum of 3 quarters · filed 2022-02-24 | $32.00M 10-K · filed 2022-02-24 | $31.00M 10-K · filed 2020-02-27 |
| 2019-09-29 | $32.00M 10-Q · filed 2020-11-05 | $32.00M derived: sum of 2 quarters · filed 2020-11-05 | $33.00M 10-Q · filed 2020-11-05 | $85.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $1.00M 10-Q · filed 2020-08-06 | $53.00M derived: sum of 3 quarters · filed 2021-02-25 | $57.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $1.00M 10-Q · filed 2020-05-07 | $53.00M derived: sum of 2 quarters · filed 2021-02-25 | $57.00M derived: sum of 3 quarters · filed 2021-02-25 | $72.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $56.00M derived: sum of 2 quarters · filed 2021-02-25 | $71.00M derived: sum of 3 quarters · filed 2021-02-25 | $71.00M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $4.00M 10-Q · filed 2019-11-07 | $19.00M derived: sum of 2 quarters · filed 2019-11-07 | $19.00M 10-Q · filed 2019-11-07 | -$55.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-07-01 | $15.00M 10-Q · filed 2019-08-08 | $22.00M 10-Q · filed 2019-08-08 | -$59.00M derived: sum of 3 quarters · filed 2020-02-27 | -$46.00M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-04-01 | $7.00M 10-Q · filed 2019-05-09 | -$74.00M derived: sum of 2 quarters · filed 2020-02-27 | -$61.00M derived: sum of 3 quarters · filed 2020-02-27 | ||
| 2017-12-31 | -$81.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$68.00M derived: sum of 2 quarters · filed 2020-02-27 | -$45.00M 10-K · filed 2020-02-27 | ||
| 2017-10-01 | $13.00M 10-Q · filed 2018-11-08 | $36.00M 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $51.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |